首页 > 最新文献

Southern African Journal of Infectious Diseases最新文献

英文 中文
Men's utilisation of sexual and reproductive health services in low- and middle-income countries: A narrative review. 低收入和中等收入国家男性对性健康和生殖健康服务的利用情况:叙述性审查。
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4102/sajid.v38i1.473
Mpumelelo Nyalela, Thembelihle Dlungwane

Background: Men have poor access to sexual and reproductive health (SRH) services globally, particularly in low- and middle-income countries (LMICs). Nevertheless, in LMIC and high-income countries (HICs), low SRH utilisation happens on account of several factors, such as individual, health system-related, and sociocultural factors. Identifying and addressing men's SRH service underutilisation remains essential to improving their sexual health and averting higher mortality and early morbidity associated with poor health seeking behaviour (HSB) among men.

Aim: This narrative review identifies factors influencing whether men do or do not utilise SRH services in LMICs.

Setting: We report on articles published in LMICs: Africa, Asia and South America.

Method: In this narrative review, we searched for quantitative and qualitative articles published between 2004 and 2021 from international databases, including Google Scholar, ScienceDirect, EBSCOhost, Scopus, PubMed, Medline, and reference lists of retrieved published articles.

Results: A total of 2219 articles were retrieved, from which 36 met the inclusion criteria. Factors contributing to poor uptake of SRH services by men included: a lack of access and availability of SRH services, poor health-seeking behaviour among men, and SRH facilities not being perceived as 'male-friendly spaces'. Furthermore, our review reveals that decreased use of SRH services is attributed to factors such as a lack of focus on men's SRH.

Conclusion: The current underutilised state of SRH services calls for urgent implementation of evidence-based interventions. Identifying men's SRH service inhibitors and enablers will assist programme managers and policymakers in designing SRH services tailored to their sexual health needs.

Contribution: Despite numerous global interventions to motivate men, the findings provide insight into the underutilisation of SRH services. The study also reveals the inadequate comprehensive investigation of men's SRH service utilisation, especially older men, to comprehend men's problems fully. Further research needs to be conducted on SRH issues, including vasectomy, mental health, and chronic conditions related to sexual and reproductive health. The analysis can assist SRH policymakers and program managers in strengthening the policies to motivate men to engage better with SRH services.

背景:在全球范围内,特别是在低收入和中等收入国家,男性获得性健康和生殖健康服务的机会很少。然而,在中低收入国家和高收入国家(HICs),由于个人因素、卫生系统相关因素和社会文化因素等多种因素,性健康和生殖健康资源利用率较低。确定和解决男性性健康和生殖健康服务未充分利用的问题,对于改善他们的性健康和避免与男性不良求医行为相关的更高死亡率和早期发病率至关重要。目的:这篇叙述性综述确定了影响中低收入国家男性是否利用性生殖健康服务的因素。环境:我们报道在中低收入国家:非洲、亚洲和南美洲发表的文章。方法:在这篇叙述性综述中,我们从国际数据库中检索了2004年至2021年间发表的定量和定性文章,包括Google Scholar、ScienceDirect、EBSCOhost、Scopus、PubMed、Medline和检索到的已发表文章的参考文献列表。结果:共检索到2219篇文献,其中36篇符合纳入标准。造成男性很少接受性健康和生殖健康服务的因素包括:缺乏获取和提供性健康和生殖健康服务的机会、男性不良的求医行为以及性健康和生殖健康设施不被视为"男性友好场所"。此外,我们的回顾显示,使用性生殖健康服务的减少可归因于缺乏对男性性生殖健康的关注等因素。结论:目前性健康和生殖健康服务未充分利用的状况要求紧急实施循证干预措施。确定男性性健康和生殖健康服务的阻碍因素和促进因素将有助于方案管理人员和决策者设计适合其性健康需求的性健康和生殖健康服务。贡献:尽管有许多全球干预措施来激励男性,但研究结果提供了对性健康和生殖健康服务利用不足的见解。该研究还揭示了对男性,特别是老年男性的性健康和生殖健康服务利用情况的全面调查不足,无法充分了解男性的问题。需要对性健康和生殖健康问题进行进一步研究,包括输精管切除术、精神健康以及与性健康和生殖健康有关的慢性疾病。分析可以帮助性健康和生殖健康政策制定者和项目经理加强政策,以激励男性更好地参与性健康和生殖健康服务。
{"title":"Men's utilisation of sexual and reproductive health services in low- and middle-income countries: A narrative review.","authors":"Mpumelelo Nyalela,&nbsp;Thembelihle Dlungwane","doi":"10.4102/sajid.v38i1.473","DOIUrl":"https://doi.org/10.4102/sajid.v38i1.473","url":null,"abstract":"<p><strong>Background: </strong>Men have poor access to sexual and reproductive health (SRH) services globally, particularly in low- and middle-income countries (LMICs). Nevertheless, in LMIC and high-income countries (HICs), low SRH utilisation happens on account of several factors, such as individual, health system-related, and sociocultural factors. Identifying and addressing men's SRH service underutilisation remains essential to improving their sexual health and averting higher mortality and early morbidity associated with poor health seeking behaviour (HSB) among men.</p><p><strong>Aim: </strong>This narrative review identifies factors influencing whether men do or do not utilise SRH services in LMICs.</p><p><strong>Setting: </strong>We report on articles published in LMICs: Africa, Asia and South America.</p><p><strong>Method: </strong>In this narrative review, we searched for quantitative and qualitative articles published between 2004 and 2021 from international databases, including Google Scholar, ScienceDirect, EBSCOhost, Scopus, PubMed, Medline, and reference lists of retrieved published articles.</p><p><strong>Results: </strong>A total of 2219 articles were retrieved, from which 36 met the inclusion criteria. Factors contributing to poor uptake of SRH services by men included: a lack of access and availability of SRH services, poor health-seeking behaviour among men, and SRH facilities not being perceived as 'male-friendly spaces'. Furthermore, our review reveals that decreased use of SRH services is attributed to factors such as a lack of focus on men's SRH.</p><p><strong>Conclusion: </strong>The current underutilised state of SRH services calls for urgent implementation of evidence-based interventions. Identifying men's SRH service inhibitors and enablers will assist programme managers and policymakers in designing SRH services tailored to their sexual health needs.</p><p><strong>Contribution: </strong>Despite numerous global interventions to motivate men, the findings provide insight into the underutilisation of SRH services. The study also reveals the inadequate comprehensive investigation of men's SRH service utilisation, especially older men, to comprehend men's problems fully. Further research needs to be conducted on SRH issues, including vasectomy, mental health, and chronic conditions related to sexual and reproductive health. The analysis can assist SRH policymakers and program managers in strengthening the policies to motivate men to engage better with SRH services.</p>","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":"38 1","pages":"473"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331170/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9812381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intensive care unit nurses' knowledge, attitudes and practices of COVID-19 infection prevention and control. 重症监护病房护士COVID-19感染防控知识、态度和做法
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4102/sajid.v38i1.478
Onga Bangani, René English, Angela Dramowski

Background: Intensive care units (ICUs) had to rapidly adapt infection prevention and control (IPC) practices during the coronavirus disease 2019 (COVID-19) pandemic.

Objectives: To determine ICU nurses' COVID-19 IPC-related knowledge, attitudes, practices, and perceptions.

Method: A mixed-methods study was conducted at the Groote Schuur Hospital ICU, Cape Town, South Africa (20 April 2021 and 30 May 2021). Participants completed anonymous, self-administered, knowledge, attitudes and practices (KAP) questionnaires. Individual interviews were conducted regarding nurses' lived experiences and perceptions of COVID-19 IPC in critical care.

Results: In total, 116 ICU nurses participated (93.5% response rate) including 57 professional nurses (49%), 34 enrolled nurses (29%) and 25 enrolled nursing assistants (22%); young females (31-49 years) predominating (n = 99; 85.3%). Nurses' overall COVID-19 IPC knowledge scores were moderately good (78%); professional nurses had greater knowledge of COVID-19 transmission (p < 0.001). Intensive care unit nurses' attitude scores towards COVID-19 IPC were low (55%), influenced by limited IPC training, insufficient time to implement IPC and shortages of personal protective equipment (PPE). Respondents' scores for self-reported COVID-19 IPC practices were moderate (65%); highest compliance rates were for hand hygiene after touching patient surroundings (68%). Only 47% ICU nurses underwent N95 respirator fit-testing despite working in a COVID-19 ICU.

Conclusion: Regular COVID-19 IPC training is needed to equip ICU nurses with the knowledge and skills to prevent healthcare-associated COVID-19 transmission. Enhanced IPC training and consistent PPE availability may support more favourable attitudes and better IPC practices. Comprehensive IPC and occupational health support should be offered to ensure ICU nurses' wellbeing during pandemics.

Contribution: Enhanced IPC training and consistent PPE availability may support better attitudes and IPC practices.

背景:在2019冠状病毒病(COVID-19)大流行期间,重症监护病房(icu)必须迅速调整感染预防和控制(IPC)实践。目的:了解ICU护士COVID-19 ipc相关知识、态度、做法和认知。方法:于2021年4月20日和2021年5月30日在南非开普敦的Groote Schuur医院ICU进行了一项混合方法研究。参与者完成了匿名、自我管理的知识、态度和实践(KAP)问卷。就护士的生活经历和对重症监护COVID-19 IPC的看法进行了个别访谈。结果:共有116名ICU护士参与调查,有效率为93.5%,其中专业护士57人(49%),登记护士34人(29%),登记护理员25人(22%);年轻女性(31-49岁)居多(n = 99;85.3%)。护士COVID-19 IPC知识总体得分为中等好(78%);专业护士对COVID-19传播的了解程度更高(p < 0.001)。重症监护病房护士对COVID-19 IPC的态度得分较低(55%),受IPC培训有限、实施IPC时间不足和个人防护装备(PPE)短缺的影响。受访者自我报告的COVID-19 IPC实践得分中等(65%);接触患者环境后的手卫生合规率最高(68%)。尽管在COVID-19重症监护室工作,但只有47%的ICU护士接受了N95口罩适配测试。结论:需要定期开展COVID-19 IPC培训,使ICU护士掌握预防卫生保健相关COVID-19传播的知识和技能。加强IPC培训和持续提供个人防护装备可能支持更有利的态度和更好的IPC实践。应提供全面的IPC和职业卫生支持,以确保重症监护病房护士在大流行期间的健康。贡献:加强IPC培训和一致的个人防护装备可用性可能支持更好的态度和IPC实践。
{"title":"Intensive care unit nurses' knowledge, attitudes and practices of COVID-19 infection prevention and control.","authors":"Onga Bangani,&nbsp;René English,&nbsp;Angela Dramowski","doi":"10.4102/sajid.v38i1.478","DOIUrl":"https://doi.org/10.4102/sajid.v38i1.478","url":null,"abstract":"<p><strong>Background: </strong>Intensive care units (ICUs) had to rapidly adapt infection prevention and control (IPC) practices during the coronavirus disease 2019 (COVID-19) pandemic.</p><p><strong>Objectives: </strong>To determine ICU nurses' COVID-19 IPC-related knowledge, attitudes, practices, and perceptions.</p><p><strong>Method: </strong>A mixed-methods study was conducted at the Groote Schuur Hospital ICU, Cape Town, South Africa (20 April 2021 and 30 May 2021). Participants completed anonymous, self-administered, knowledge, attitudes and practices (KAP) questionnaires. Individual interviews were conducted regarding nurses' lived experiences and perceptions of COVID-19 IPC in critical care.</p><p><strong>Results: </strong>In total, 116 ICU nurses participated (93.5% response rate) including 57 professional nurses (49%), 34 enrolled nurses (29%) and 25 enrolled nursing assistants (22%); young females (31-49 years) predominating (<i>n</i> = 99; 85.3%). Nurses' overall COVID-19 IPC knowledge scores were moderately good (78%); professional nurses had greater knowledge of COVID-19 transmission (<i>p</i> < 0.001). Intensive care unit nurses' attitude scores towards COVID-19 IPC were low (55%), influenced by limited IPC training, insufficient time to implement IPC and shortages of personal protective equipment (PPE). Respondents' scores for self-reported COVID-19 IPC practices were moderate (65%); highest compliance rates were for hand hygiene after touching patient surroundings (68%). Only 47% ICU nurses underwent N95 respirator fit-testing despite working in a COVID-19 ICU.</p><p><strong>Conclusion: </strong>Regular COVID-19 IPC training is needed to equip ICU nurses with the knowledge and skills to prevent healthcare-associated COVID-19 transmission. Enhanced IPC training and consistent PPE availability may support more favourable attitudes and better IPC practices. Comprehensive IPC and occupational health support should be offered to ensure ICU nurses' wellbeing during pandemics.</p><p><strong>Contribution: </strong>Enhanced IPC training and consistent PPE availability may support better attitudes and IPC practices.</p>","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":"38 1","pages":"478"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9817934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescribing patterns of echinocandins in adult patients in a private hospital in Gauteng, South Africa. 南非豪登省一家私立医院成年患者棘白菌素的处方模式。
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4102/sajid.v38i1.470
Anja Grey, Rianda Joubert, Stephan Steyn, Marlene Julyan

Background: Worldwide, the leading cause of invasive candidiasis and the fourth leading cause of hospital-acquired infections are the Candida species (spp.) group. One of the most important tools in fighting such drug-resistant fungi is the appropriate use of antifungal agents.

Objectives: The study aimed to determine echinocandins' general prescribing patterns and how they are associated with the treatment period.

Method: A quantitative, observational, and descriptive was used, and included patients receiving antifungal treatment in a private hospital in Gauteng, South Africa between 01 January 2015 to 31 December 2015.

Results: Of the 146 patient files included, 102 patients (69.9%) received caspofungin and 44 patients (30.1%) were treated with anidulafungin. For the former, 99 (97.1%) patients received a loading dose (LD) of 70 mg, while 200 mg anidulafungin was only prescribed to 30 patients (68.2%). In line with maintenance dose guidelines, the majority (98.1%) of caspofungin-treated patients received 50 mg IV daily, whereas 4 (3.9%) patients were treated at higher doses (70 mg daily). Anidulafungin was administered at various maintenance doses, including 400 mg (2.3% of patients), 200 mg (52.3%), 100 mg (43.2%) and 50 mg (2.3%) IV daily.

Conclusion: Our results can be utilised to produce a hospital-specific algorithm in terms of Candida-infected patients.

Contribution: These findings contribute to our understanding of prescribing patterns of antifungal agents and the impact thereof on treating Candida spp. Infections.

背景:在世界范围内,侵袭性念珠菌病的主要原因和医院获得性感染的第四大原因是念珠菌种(种)组。对抗此类耐药真菌的最重要工具之一是适当使用抗真菌剂。目的:本研究旨在确定棘白菌素的一般处方模式及其与治疗期的关系。方法:采用定量、观察和描述性方法,纳入2015年1月1日至2015年12月31日在南非豪登省一家私立医院接受抗真菌治疗的患者。结果:纳入的146例患者中,102例(69.9%)患者接受了卡泊芬净治疗,44例(30.1%)患者接受了阿尼杜芬净治疗。对于前者,99例(97.1%)患者的负荷剂量(LD)为70 mg,而anidulafungin的负荷剂量(LD)仅为30例(68.2%)。根据维持剂量指南,大多数(98.1%)接受caspofungin治疗的患者每天接受50mg静脉注射,而4名(3.9%)患者接受更高剂量(每天70mg)治疗。Anidulafungin以不同的维持剂量给予,包括每日400mg(2.3%的患者)、200mg(52.3%)、100mg(43.2%)和50mg(2.3%)静脉注射。结论:我们的结果可用于生产医院特异性算法在念珠菌感染的病人。贡献:这些发现有助于我们理解抗真菌药物的处方模式及其对治疗念珠菌感染的影响。
{"title":"Prescribing patterns of echinocandins in adult patients in a private hospital in Gauteng, South Africa.","authors":"Anja Grey,&nbsp;Rianda Joubert,&nbsp;Stephan Steyn,&nbsp;Marlene Julyan","doi":"10.4102/sajid.v38i1.470","DOIUrl":"https://doi.org/10.4102/sajid.v38i1.470","url":null,"abstract":"<p><strong>Background: </strong>Worldwide, the leading cause of invasive candidiasis and the fourth leading cause of hospital-acquired infections are the Candida species (spp.) group. One of the most important tools in fighting such drug-resistant fungi is the appropriate use of antifungal agents.</p><p><strong>Objectives: </strong>The study aimed to determine echinocandins' general prescribing patterns and how they are associated with the treatment period.</p><p><strong>Method: </strong>A quantitative, observational, and descriptive was used, and included patients receiving antifungal treatment in a private hospital in Gauteng, South Africa between 01 January 2015 to 31 December 2015.</p><p><strong>Results: </strong>Of the 146 patient files included, 102 patients (69.9%) received caspofungin and 44 patients (30.1%) were treated with anidulafungin. For the former, 99 (97.1%) patients received a loading dose (LD) of 70 mg, while 200 mg anidulafungin was only prescribed to 30 patients (68.2%). In line with maintenance dose guidelines, the majority (98.1%) of caspofungin-treated patients received 50 mg IV daily, whereas 4 (3.9%) patients were treated at higher doses (70 mg daily). Anidulafungin was administered at various maintenance doses, including 400 mg (2.3% of patients), 200 mg (52.3%), 100 mg (43.2%) and 50 mg (2.3%) IV daily.</p><p><strong>Conclusion: </strong>Our results can be utilised to produce a hospital-specific algorithm in terms of Candida-infected patients.</p><p><strong>Contribution: </strong>These findings contribute to our understanding of prescribing patterns of antifungal agents and the impact thereof on treating <i>Candida</i> spp. Infections.</p>","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":"38 1","pages":"470"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9316209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ebola outbreak in Guinea, 2021: Clinical care of patients with Ebola virus disease. 2021年几内亚埃博拉疫情:埃博拉病毒病患者的临床护理
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4102/sajid.v38i1.454
Boyo C Pare, Alseny M Camara, Aminata Camara, Moussa Kourouma, Koivogui Enogo, Mohammed S Camara, Laurent Akilimali, Sayadi Sani, Eric Barte de Sainte Fare, Papys Lame, Nicolas Mouly, Marta Lado Castro-Rial, Billy Sivahera, Mahamoud S Cherif, Abdoul H Beavogui, Dally Muamba, Joachim B Tamba, Barry Moumié, Richard Kojan, Hans-Joerg Lang

Background: Experience from the Zaire Ebolavirus epidemic in the eastern Democratic Republic of the Congo (2018-2020) demonstrates that early initiation of essential critical care and administration of Zaire Ebolavirus specific monoclonal antibodies may be associated with improved outcomes among patients with Ebola virus disease (EVD).

Objectives: This series describes 13 EVD patients and 276 patients with suspected EVD treated during a Zaire Ebolavirus outbreak in Guinea in 2021.

Method: Patients with confirmed or suspected EVD were treated in two Ebola treatment centres (ETC) in the region of N'zérékoré. Data were reviewed from all patients with suspected or confirmed EVD hospitalised in these two ETCs during the outbreak (14 February 2021 - 19 June 2021). Ebola-specific monoclonal antibodies, were available 2 weeks after onset of the outbreak.

Results: Nine of the 13 EVD patients (age range: 22-70 years) survived. The four EVD patients who died, including one pregnant woman, presented with multi-organ dysfunction and died within 48 h of admission. All eight patients who received Ebola-specific monoclonal antibodies survived. Four of the 13 EVD patients were health workers. Improvement of ETC design facilitated implementation of WHO-recommended 'optimized supportive care for EVD'. In this context, pragmatic clinical training was integrated in routine ETC activities. Initial clinical manifestations of 13 confirmed EVD patients were similar to those of 276 patients with suspected, but subsequently non confirmed EVD. These patients suffered from other acute infections (e.g. malaria in 183 of 276 patients; 66%). Five of the 276 patients with suspected EVD died. One of these five patients had Lassa virus disease and a coronavirus disease 2019 (COVID-19) co-infection.

Conclusion: Multidisciplinary outbreak response teams can rapidly optimise ETC design. Trained clinical teams can provide WHO-recommended optimised supportive care, including safe administration of Ebola-specific monoclonal antibodies. Pragmatic training in essential critical care can be integrated in routine ETC activities.

Contribution: This article describes clinical realities associated with implementation of WHO-recommended standards of 'optimized supportive care' and administration of Ebola virus specific treatments. In this context, the importance of essential design principles of ETCs is underlined, which allow continuous visual contact and verbal interaction of health workers and families with their patients. Elements that may contribute to further quality of care improvements for patients with confirmed or suspected EVD are discussed.

背景:刚果民主共和国东部扎伊尔埃博拉病毒流行(2018-2020年)的经验表明,早期开始基本重症监护和给予扎伊尔埃博拉病毒特异性单克隆抗体可能与改善埃博拉病毒病(EVD)患者的预后有关。目的:本系列描述了2021年几内亚扎伊尔埃博拉病毒暴发期间治疗的13名埃博拉病毒病患者和276名疑似埃博拉病毒病患者。方法:对确诊或疑似EVD患者在恩扎伊姆萨伊地区的两个埃博拉治疗中心(ETC)进行治疗。对疫情暴发期间(2021年2月14日至2021年6月19日)在这两个ETCs住院的所有疑似或确诊埃博拉病毒病患者的数据进行了审查。在疫情发生2周后可获得埃博拉特异性单克隆抗体。结果:13例EVD患者中9例存活,年龄22 ~ 70岁。死亡的4例EVD患者,包括1名孕妇,均出现多器官功能障碍,并在入院48小时内死亡。接受埃博拉特异性单克隆抗体治疗的8名患者全部存活。13名埃博拉患者中有4名是卫生工作者。ETC设计的改进促进了世卫组织建议的“埃博拉病毒病优化支持性护理”的实施。在这种情况下,实用的临床培训被纳入日常的ETC活动。13例确诊埃博拉病毒病患者的初始临床表现与276例疑似埃博拉病毒病患者相似,但随后未确诊。这些患者患有其他急性感染(例如,276名患者中有183名患有疟疾;66%)。276名疑似埃博拉病毒病患者中有5人死亡。这五名患者中有一人同时感染了拉沙病毒病和2019年冠状病毒病(COVID-19)。结论:多学科疫情响应团队可快速优化ETC设计。训练有素的临床小组可以提供世卫组织推荐的优化支持性护理,包括安全给药埃博拉特异性单克隆抗体。关键重症监护方面的实用培训可以纳入日常的ETC活动。贡献:本文描述了与实施世卫组织推荐的“优化支持性护理”标准和实施埃博拉病毒特异性治疗相关的临床现实。在这种情况下,强调了ETCs基本设计原则的重要性,这些原则允许卫生工作者和家属与患者进行持续的视觉接触和口头互动。讨论了可能有助于进一步改善确诊或疑似埃博拉病毒病患者护理质量的因素。
{"title":"Ebola outbreak in Guinea, 2021: Clinical care of patients with Ebola virus disease.","authors":"Boyo C Pare,&nbsp;Alseny M Camara,&nbsp;Aminata Camara,&nbsp;Moussa Kourouma,&nbsp;Koivogui Enogo,&nbsp;Mohammed S Camara,&nbsp;Laurent Akilimali,&nbsp;Sayadi Sani,&nbsp;Eric Barte de Sainte Fare,&nbsp;Papys Lame,&nbsp;Nicolas Mouly,&nbsp;Marta Lado Castro-Rial,&nbsp;Billy Sivahera,&nbsp;Mahamoud S Cherif,&nbsp;Abdoul H Beavogui,&nbsp;Dally Muamba,&nbsp;Joachim B Tamba,&nbsp;Barry Moumié,&nbsp;Richard Kojan,&nbsp;Hans-Joerg Lang","doi":"10.4102/sajid.v38i1.454","DOIUrl":"https://doi.org/10.4102/sajid.v38i1.454","url":null,"abstract":"<p><strong>Background: </strong>Experience from the Zaire Ebolavirus epidemic in the eastern Democratic Republic of the Congo (2018-2020) demonstrates that early initiation of essential critical care and administration of Zaire Ebolavirus specific monoclonal antibodies may be associated with improved outcomes among patients with Ebola virus disease (EVD).</p><p><strong>Objectives: </strong>This series describes 13 EVD patients and 276 patients with suspected EVD treated during a Zaire Ebolavirus outbreak in Guinea in 2021.</p><p><strong>Method: </strong>Patients with confirmed or suspected EVD were treated in two Ebola treatment centres (ETC) in the region of N'zérékoré. Data were reviewed from all patients with suspected or confirmed EVD hospitalised in these two ETCs during the outbreak (14 February 2021 - 19 June 2021). Ebola-specific monoclonal antibodies, were available 2 weeks after onset of the outbreak.</p><p><strong>Results: </strong>Nine of the 13 EVD patients (age range: 22-70 years) survived. The four EVD patients who died, including one pregnant woman, presented with multi-organ dysfunction and died within 48 h of admission. All eight patients who received Ebola-specific monoclonal antibodies survived. Four of the 13 EVD patients were health workers. Improvement of ETC design facilitated implementation of WHO-recommended 'optimized supportive care for EVD'. In this context, pragmatic clinical training was integrated in routine ETC activities. Initial clinical manifestations of 13 confirmed EVD patients were similar to those of 276 patients with suspected, but subsequently non confirmed EVD. These patients suffered from other acute infections (e.g. malaria in 183 of 276 patients; 66%). Five of the 276 patients with suspected EVD died. One of these five patients had Lassa virus disease and a coronavirus disease 2019 (COVID-19) co-infection.</p><p><strong>Conclusion: </strong>Multidisciplinary outbreak response teams can rapidly optimise ETC design. Trained clinical teams can provide WHO-recommended optimised supportive care, including safe administration of Ebola-specific monoclonal antibodies. Pragmatic training in essential critical care can be integrated in routine ETC activities.</p><p><strong>Contribution: </strong>This article describes clinical realities associated with implementation of WHO-recommended standards of 'optimized supportive care' and administration of Ebola virus specific treatments. In this context, the importance of essential design principles of ETCs is underlined, which allow continuous visual contact and verbal interaction of health workers and families with their patients. Elements that may contribute to further quality of care improvements for patients with confirmed or suspected EVD are discussed.</p>","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":"38 1","pages":"454"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and clinical manifestations of Bancroftian filariasis in northern Taraba State, Nigeria 尼日利亚塔拉巴州北部班克罗夫特丝虫病的流行和临床表现
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2022-06-01 DOI: 10.4102/sajid.v37i1.250
S. O. Elkanah, Deborah S. Elkanah, D. Akafyi, S. Kela, G. Anyanwu, A. Samaila
{"title":"Prevalence and clinical manifestations of Bancroftian filariasis in northern Taraba State, Nigeria","authors":"S. O. Elkanah, Deborah S. Elkanah, D. Akafyi, S. Kela, G. Anyanwu, A. Samaila","doi":"10.4102/sajid.v37i1.250","DOIUrl":"https://doi.org/10.4102/sajid.v37i1.250","url":null,"abstract":"","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":"1 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43254841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D status and COVID-19 severity 维生素D状况与COVID-19严重程度
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2022-04-26 DOI: 10.4102/sajid.v37i1.359
Senrina Kalichuran, S. V. van Blydenstein, M. Venter, S. Omar
Background Age, body mass index (BMI) and pre-existing comorbidities are known risk factors of severe coronavirus disease 2019 (COVID-19). In this study we explore the relationship between vitamin D status and COVID-19 severity. Methods We conducted a prospective, cross-sectional descriptive study. We enrolled 100 COVID-19 positive patients admitted to a tertiary level hospital in Johannesburg, South Africa. Fifty had symptomatic disease (COVID-19 pneumonia) and 50 who were asymptomatic (incidental diagnosis). Following written informed consent, patients were interviewed regarding age, gender and sunlight exposure during the past week, disease severity, BMI, calcium, albumin, magnesium and alkaline phosphatase levels. Finally, blood was collected for vitamin D measurement. Results We found an 82% prevalence rate of vitamin D deficiency or insufficiency among COVID-19 patients. Vitamin D levels were lower in the symptomatic group (18.1 ng/mL ± 8.1 ng/mL) than the asymptomatic group (25.9 ng/mL ± 7.1 ng/mL) with a p-value of 0.000. The relative risk of symptomatic COVID-19 was 2.5-fold higher among vitamin D deficient patients than vitamin D non-deficient patients (confidence interval [CI]: 1.14–3.26). Additional predictors of symptomatic disease were older age, hypocalcaemia and hypoalbuminaemia. Using multiple regression, the only independent predictors of COVID-19 severity were age and vitamin D levels. The patients exposed to less sunlight had a 2.39-fold increased risk for symptomatic disease compared to those with more sunlight exposure (CI: 1.32–4.33). Conclusion We found a high prevalence of vitamin D deficiency and insufficiency among patients admitted to hospital with COVID-19 and an increased risk for symptomatic disease in vitamin D deficient patients.
年龄、体重指数(BMI)和已有的合并症是已知的2019年严重冠状病毒病(COVID-19)的危险因素。在这项研究中,我们探讨了维生素D水平与COVID-19严重程度之间的关系。方法我们进行了一项前瞻性、横断面描述性研究。我们招募了100名在南非约翰内斯堡一家三级医院住院的COVID-19阳性患者。50例有症状(COVID-19肺炎),50例无症状(偶然诊断)。在获得书面知情同意后,对患者进行了关于年龄、性别和过去一周的日照情况、疾病严重程度、BMI、钙、白蛋白、镁和碱性磷酸酶水平的访谈。最后,采集血液进行维生素D测定。结果我们发现COVID-19患者中维生素D缺乏或不足的患病率为82%。有症状组维生素D水平(18.1 ng/mL±8.1 ng/mL)低于无症状组(25.9 ng/mL±7.1 ng/mL), p值为0.000。维生素D缺乏患者出现症状性COVID-19的相对风险是非维生素D缺乏患者的2.5倍(可信区间[CI]: 1.14-3.26)。有症状疾病的其他预测因素是年龄较大、低钙血症和低白蛋白血症。使用多元回归,COVID-19严重程度的唯一独立预测因子是年龄和维生素D水平。日照较少的患者与日照较多的患者相比,出现症状性疾病的风险增加了2.39倍(CI: 1.32-4.33)。结论:我们发现COVID-19住院患者中维生素D缺乏和功能不全的患病率较高,维生素D缺乏患者出现症状性疾病的风险增加。
{"title":"Vitamin D status and COVID-19 severity","authors":"Senrina Kalichuran, S. V. van Blydenstein, M. Venter, S. Omar","doi":"10.4102/sajid.v37i1.359","DOIUrl":"https://doi.org/10.4102/sajid.v37i1.359","url":null,"abstract":"Background Age, body mass index (BMI) and pre-existing comorbidities are known risk factors of severe coronavirus disease 2019 (COVID-19). In this study we explore the relationship between vitamin D status and COVID-19 severity. Methods We conducted a prospective, cross-sectional descriptive study. We enrolled 100 COVID-19 positive patients admitted to a tertiary level hospital in Johannesburg, South Africa. Fifty had symptomatic disease (COVID-19 pneumonia) and 50 who were asymptomatic (incidental diagnosis). Following written informed consent, patients were interviewed regarding age, gender and sunlight exposure during the past week, disease severity, BMI, calcium, albumin, magnesium and alkaline phosphatase levels. Finally, blood was collected for vitamin D measurement. Results We found an 82% prevalence rate of vitamin D deficiency or insufficiency among COVID-19 patients. Vitamin D levels were lower in the symptomatic group (18.1 ng/mL ± 8.1 ng/mL) than the asymptomatic group (25.9 ng/mL ± 7.1 ng/mL) with a p-value of 0.000. The relative risk of symptomatic COVID-19 was 2.5-fold higher among vitamin D deficient patients than vitamin D non-deficient patients (confidence interval [CI]: 1.14–3.26). Additional predictors of symptomatic disease were older age, hypocalcaemia and hypoalbuminaemia. Using multiple regression, the only independent predictors of COVID-19 severity were age and vitamin D levels. The patients exposed to less sunlight had a 2.39-fold increased risk for symptomatic disease compared to those with more sunlight exposure (CI: 1.32–4.33). Conclusion We found a high prevalence of vitamin D deficiency and insufficiency among patients admitted to hospital with COVID-19 and an increased risk for symptomatic disease in vitamin D deficient patients.","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46499652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
COVID-19 death: A novel method of improving its identification when a patient has multiple diagnoses COVID-19死亡:当患者有多种诊断时提高其识别的新方法
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2022-04-26 DOI: 10.4102/sajid.v37i1.349
N. Ngene, J. Moodley
Assigning a primary cause of death to a deceased patient who had multiple principal diagnoses including coronavirus disease 2019 (COVID-19) is challenging because of the difficulty in selecting the most appropriate cause. To proffer a solution, the authors reviewed the literature on assigning a primary cause of death. In 2015, the Nnabuike-Jagidesa (NJ) model II was devised to improve the International Classification of Diseases and related health problems, 10th revision (ICD-10) guideline on how to assign a primary cause of death. The NJ model II stipulates that when there are multiple diagnoses with no plausible explanation that one of the illnesses could have resulted in the other clinical conditions, the single most appropriate primary cause of death is the condition with the highest case fatality ratio in that setting. In the index report, the authors opine that if the case fatality ratios are similar, the following objective criteria (listed in the order of priority) should be used to assign a primary cause of death: condition with the highest infection fatality ratio, condition that was the main indication for the last acute surgical or invasive procedure performed (during the course of the same ill-health) before the death and the disease that theoretically affects the highest number of body organs. Additionally, a clinical descriptor should be used when none of the objective criteria are satisfied. This novel approach, termed the modified NJ model II, is expected to improve the objectivity and reproducibility of the assigned primary cause of death in a deceased who had multiple diagnoses, which may include COVID-19.
将主要死因分配给患有多种主要诊断(包括2019冠状病毒病(新冠肺炎)的已故患者具有挑战性,因为很难选择最合适的病因。为了提供一个解决方案,作者回顾了有关指定主要死因的文献。2015年,Nnabuike-Jagidesa(NJ)模型II被设计用于改进国际疾病分类和相关健康问题第10次修订版(ICD-10)关于如何分配主要死因的指南。NJ模型II规定,当有多种诊断,但没有合理的解释表明其中一种疾病可能导致其他临床疾病时,最合适的主要死因是该环境中病死率最高的疾病。在指数报告中,作者认为,如果病死率相似,则应使用以下客观标准(按优先顺序列出)来确定主要死因:感染致死率最高的情况,这种情况是死亡前最后一次进行急性手术或侵入性手术(在同一健康状况下)的主要指征,也是理论上影响身体器官数量最多的疾病。此外,当不满足任何客观标准时,应使用临床描述符。这种被称为改良NJ模型II的新方法有望提高多重诊断(可能包括新冠肺炎)死者主要死因的客观性和可重复性。
{"title":"COVID-19 death: A novel method of improving its identification when a patient has multiple diagnoses","authors":"N. Ngene, J. Moodley","doi":"10.4102/sajid.v37i1.349","DOIUrl":"https://doi.org/10.4102/sajid.v37i1.349","url":null,"abstract":"Assigning a primary cause of death to a deceased patient who had multiple principal diagnoses including coronavirus disease 2019 (COVID-19) is challenging because of the difficulty in selecting the most appropriate cause. To proffer a solution, the authors reviewed the literature on assigning a primary cause of death. In 2015, the Nnabuike-Jagidesa (NJ) model II was devised to improve the International Classification of Diseases and related health problems, 10th revision (ICD-10) guideline on how to assign a primary cause of death. The NJ model II stipulates that when there are multiple diagnoses with no plausible explanation that one of the illnesses could have resulted in the other clinical conditions, the single most appropriate primary cause of death is the condition with the highest case fatality ratio in that setting. In the index report, the authors opine that if the case fatality ratios are similar, the following objective criteria (listed in the order of priority) should be used to assign a primary cause of death: condition with the highest infection fatality ratio, condition that was the main indication for the last acute surgical or invasive procedure performed (during the course of the same ill-health) before the death and the disease that theoretically affects the highest number of body organs. Additionally, a clinical descriptor should be used when none of the objective criteria are satisfied. This novel approach, termed the modified NJ model II, is expected to improve the objectivity and reproducibility of the assigned primary cause of death in a deceased who had multiple diagnoses, which may include COVID-19.","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47718905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Microbiologic characterisation of bacterial infections in children with atopic dermatitis 特应性皮炎患儿细菌感染的微生物学特征
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2022-03-31 DOI: 10.4102/sajid.v37i1.368
Nkosinathi O. Zwane, J. T. Masuka, A. Chateau, A. Mosam
Background Patients with atopic dermatitis (AD), the commonest chronic inflammatory skin disease are often colonised and infected by Staphylococcus aureus. In this study, we aimed to determine the type and antibacterial sensitivities of the bacteria infecting eczematous lesions in children with AD and to recommend first-line antibiotic therapy. Methods A prospective study was conducted from June 2020 to June 2021 in children with AD presenting with a cutaneous infection at the King Edward hospital VIII outpatient dermatology clinic. Swabs were collected for microbial culture, confirming infections and assessing antibiotic sensitivity for infected sites. Results Ninety six children were recruited during the study period with a mean age of 4.3 ± 3.4 years. The commonest cause of bacterial infection was Staphylococcus aureus seen in 74 (77.1%) cases, followed by Staphylococcus aureus and Group A β-haemolytic streptococcus (GAS) co-infection in 22 (22.9%) cases. The majority of these infections were observed on the lower limbs in 50 (52.08%) cases and in moderate 37 (38.5%) cases and severe eczema cases of 38 (39.6%) in AD. There was no gender predilection. Staphylococcus aureus was sensitive to amoxicillin-clavulanic acid in 57 (77.0%) cases, cloxacillin in 53 (71.6%) cases and clindamycin in 24 (32.4%) cases, whereas GAS was mostly sensitive to ampicillin in 10 (45.5%) cases. No swabs retained a resistant strain. Conclusion Staphylococcus aureus is the commonest bacterial cause of cutaneous infection in children with AD in our setting. Amoxicillin-clavulanic acid and cloxacillin remain the most sensitive therapeutic options for this infection, however, a larger study is required to explore resistance strains, if any, in our setting.
背景特应性皮炎(AD)是最常见的慢性炎症性皮肤病,患者经常被金黄色葡萄球菌定植和感染。在这项研究中,我们旨在确定感染AD儿童湿疹样病变的细菌的类型和抗菌敏感性,并推荐一线抗生素治疗。方法于2020年6月至2021年6月在爱德华国王医院第八医院皮肤科门诊对出现皮肤感染的AD儿童进行前瞻性研究。采集拭子进行微生物培养,确认感染并评估感染部位的抗生素敏感性。结果在研究期间招募了96名儿童,平均年龄为4.3±3.4岁。细菌感染最常见的原因是74例(77.1%)病例中出现的金黄色葡萄球菌,其次是22例(22.9%)病例中的金黄色葡球菌和A组β-溶血性链球菌(GAS)共同感染。在AD中,50例(52.08%)、37例(38.5%)中度湿疹和38例(39.6%)重度湿疹的下肢感染占大多数。没有性别偏好。金黄色葡萄球菌对阿莫西林-克拉维酸敏感57例(77.0%),氯唑西林敏感53例(71.6%),克林霉素敏感24例(32.4%),而GAS对氨苄青霉素最敏感10例(45.5%)。没有任何拭子保留了耐药菌株。结论金黄色葡萄球菌是AD患儿皮肤感染最常见的细菌原因。阿莫西林-克拉维酸和氯唑西林仍然是这种感染最敏感的治疗选择,然而,需要进行更大规模的研究来探索我们环境中的耐药性菌株(如果有的话)。
{"title":"Microbiologic characterisation of bacterial infections in children with atopic dermatitis","authors":"Nkosinathi O. Zwane, J. T. Masuka, A. Chateau, A. Mosam","doi":"10.4102/sajid.v37i1.368","DOIUrl":"https://doi.org/10.4102/sajid.v37i1.368","url":null,"abstract":"Background Patients with atopic dermatitis (AD), the commonest chronic inflammatory skin disease are often colonised and infected by Staphylococcus aureus. In this study, we aimed to determine the type and antibacterial sensitivities of the bacteria infecting eczematous lesions in children with AD and to recommend first-line antibiotic therapy. Methods A prospective study was conducted from June 2020 to June 2021 in children with AD presenting with a cutaneous infection at the King Edward hospital VIII outpatient dermatology clinic. Swabs were collected for microbial culture, confirming infections and assessing antibiotic sensitivity for infected sites. Results Ninety six children were recruited during the study period with a mean age of 4.3 ± 3.4 years. The commonest cause of bacterial infection was Staphylococcus aureus seen in 74 (77.1%) cases, followed by Staphylococcus aureus and Group A β-haemolytic streptococcus (GAS) co-infection in 22 (22.9%) cases. The majority of these infections were observed on the lower limbs in 50 (52.08%) cases and in moderate 37 (38.5%) cases and severe eczema cases of 38 (39.6%) in AD. There was no gender predilection. Staphylococcus aureus was sensitive to amoxicillin-clavulanic acid in 57 (77.0%) cases, cloxacillin in 53 (71.6%) cases and clindamycin in 24 (32.4%) cases, whereas GAS was mostly sensitive to ampicillin in 10 (45.5%) cases. No swabs retained a resistant strain. Conclusion Staphylococcus aureus is the commonest bacterial cause of cutaneous infection in children with AD in our setting. Amoxicillin-clavulanic acid and cloxacillin remain the most sensitive therapeutic options for this infection, however, a larger study is required to explore resistance strains, if any, in our setting.","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42025423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Theoretical origin of genetically homologous Plasmodium vivax malarial recurrences 基因同源间日疟原虫疟疾复发的理论起源
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2022-03-30 DOI: 10.4102/sajid.v37i1.369
M. Markus
Malaria caused by Plasmodium vivax is being diagnosed with increasing frequency in Africa. Some southern countries where it has been detected are Angola, Botswana, Mozambique, Namibia, Zambia and Zimbabwe. Knowing the parasite origin of P. vivax infection recurrences (which can be reinfections, recrudescences or relapses) is important epidemiologically for malaria elimination in Africa. Although hypnozoites will no doubt be a source, we should try to determine how frequently the origin of non-reinfection recurrences of P. vivax malaria involving closely related parasites may be non-circulating merozoites rather than hypnozoites.
间日疟原虫引起的疟疾在非洲的诊断频率越来越高。安哥拉、博茨瓦纳、莫桑比克、纳米比亚、赞比亚和津巴布韦是发现该病毒的南部国家。了解间日疟原虫感染复发的寄生虫来源(可能是再次感染、复发或复发)对非洲消灭疟疾具有重要的流行病学意义。尽管裂殖虫无疑是一个来源,但我们应该尝试确定间日疟原虫非再感染复发的密切相关寄生虫的来源可能是非循环裂殖子而不是裂殖虫。
{"title":"Theoretical origin of genetically homologous Plasmodium vivax malarial recurrences","authors":"M. Markus","doi":"10.4102/sajid.v37i1.369","DOIUrl":"https://doi.org/10.4102/sajid.v37i1.369","url":null,"abstract":"Malaria caused by Plasmodium vivax is being diagnosed with increasing frequency in Africa. Some southern countries where it has been detected are Angola, Botswana, Mozambique, Namibia, Zambia and Zimbabwe. Knowing the parasite origin of P. vivax infection recurrences (which can be reinfections, recrudescences or relapses) is important epidemiologically for malaria elimination in Africa. Although hypnozoites will no doubt be a source, we should try to determine how frequently the origin of non-reinfection recurrences of P. vivax malaria involving closely related parasites may be non-circulating merozoites rather than hypnozoites.","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49024034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A retrospective review of calls to the Poisons Information Helpline of the Western Cape during the first 6 months of the COVID-19 pandemic in South Africa 对南非新冠肺炎大流行前6个月致电西开普省毒物信息求助热线的回顾性审查
IF 0.9 Q4 INFECTIOUS DISEASES Pub Date : 2022-03-30 DOI: 10.4102/sajid.v37i1.391
C. D. du Plessis, Farah Mohamed, C. Stephen, H. Reuter, Gonwayne Voigt, D. V. van Hoving, C. Marks
Background Since the start of the coronavirus disease 2019 (COVID-19) pandemic, poison centres worldwide have reported an increase in exposures to chemicals used for infection prevention. Increased availability and use could lead to an increase in exposures. Potential effects on a South African Poison Information Helpline were unknown, therefore a study was performed to describe changes in call volume and profile of poison exposures. Methods A retrospective analysis was conducted on an observational database of telephone enquiries. All human-related poisoning exposure call data collected from 01 March to 31 August during 2018, 2019 and 2020 were extracted and analysed. Summary statistics were used to describe all variables. Results The total number of calls were 5137, 5508, and 5181 in 2018, 2019, 2020, respectively. The monthly call number during 2020 was mostly less than in 2019. More calls were received from the public calls (39.4% vs 33.1%) and for accidental exposures (65.6% vs 62.3%) increased during 2020 compared to 2019. Exposures to pharmaceuticals decreased by 14.8% from 2019 to 2020, while exposures to eucalyptus oil more than doubled from 21 in 2019 to 43 during 2020. Exposures to antiseptics and disinfectants increased by 60.4%, mainly due to hand sanitisers exposure which showed a 26-fold increase from 2019 (n = 6) to 2020 (n = 156). Conclusion A change in the profile of poison exposures was observed during the COVID-19 pandemic. Lockdown regulations and greater availability of antiseptics and disinfectants probably led to the increase in exposures. Although symptoms were mostly mild, the public should be educated on safe storage and proper use of all chemicals.
背景自2019冠状病毒病(新冠肺炎)大流行开始以来,世界各地的毒物中心报告称,用于预防感染的化学品暴露量增加。可用性和使用量的增加可能会导致风险敞口的增加。对南非毒物信息热线的潜在影响尚不清楚,因此进行了一项研究,以描述呼叫量和毒物暴露情况的变化。方法对电话咨询的观察数据库进行回顾性分析。提取并分析了2018年、2019年和2020年3月1日至8月31日期间收集的所有与人类相关的中毒暴露电话数据。摘要统计数据用于描述所有变量。结果2018年、2019年和2020年的电话总数分别为5137、5508和5181。2020年的月度电话号码大多低于2019年。与2019年相比,2020年接到的公众电话(39.4%对33.1%)和意外暴露电话(65.6%对62.3%)增加了。从2019年到2020年,对药品的敞口减少了14.8%,而对桉树油的敞口增加了一倍多,从2019年的21个增加到2020年的43个。防腐剂和消毒剂的暴露量增加了60.4%,主要是由于洗手液的暴露量从2019年(n=6)到2020年(n=156)增加了26倍。结论新冠肺炎疫情期间毒物暴露状况发生了变化。封锁规定和防腐剂和消毒剂的更多可用性可能导致暴露量的增加。尽管症状大多较轻,但应教育公众安全储存和正确使用所有化学品。
{"title":"A retrospective review of calls to the Poisons Information Helpline of the Western Cape during the first 6 months of the COVID-19 pandemic in South Africa","authors":"C. D. du Plessis, Farah Mohamed, C. Stephen, H. Reuter, Gonwayne Voigt, D. V. van Hoving, C. Marks","doi":"10.4102/sajid.v37i1.391","DOIUrl":"https://doi.org/10.4102/sajid.v37i1.391","url":null,"abstract":"Background Since the start of the coronavirus disease 2019 (COVID-19) pandemic, poison centres worldwide have reported an increase in exposures to chemicals used for infection prevention. Increased availability and use could lead to an increase in exposures. Potential effects on a South African Poison Information Helpline were unknown, therefore a study was performed to describe changes in call volume and profile of poison exposures. Methods A retrospective analysis was conducted on an observational database of telephone enquiries. All human-related poisoning exposure call data collected from 01 March to 31 August during 2018, 2019 and 2020 were extracted and analysed. Summary statistics were used to describe all variables. Results The total number of calls were 5137, 5508, and 5181 in 2018, 2019, 2020, respectively. The monthly call number during 2020 was mostly less than in 2019. More calls were received from the public calls (39.4% vs 33.1%) and for accidental exposures (65.6% vs 62.3%) increased during 2020 compared to 2019. Exposures to pharmaceuticals decreased by 14.8% from 2019 to 2020, while exposures to eucalyptus oil more than doubled from 21 in 2019 to 43 during 2020. Exposures to antiseptics and disinfectants increased by 60.4%, mainly due to hand sanitisers exposure which showed a 26-fold increase from 2019 (n = 6) to 2020 (n = 156). Conclusion A change in the profile of poison exposures was observed during the COVID-19 pandemic. Lockdown regulations and greater availability of antiseptics and disinfectants probably led to the increase in exposures. Although symptoms were mostly mild, the public should be educated on safe storage and proper use of all chemicals.","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48676036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Southern African Journal of Infectious Diseases
全部 Int. J. Biometeorol. Archaeol. Anthropol. Sci. Geochem. Int. J. Atmos. Oceanic Technol. PALAEOGEOGR PALAEOCL Aust. J. Earth Sci. TECTONOPHYSICS Earth Syst. Dyn. Swiss J. Geosci. J. Geog. Sci. Acta Geophys. J. Spatial Sci. ARCT ANTARCT ALP RES Appl. Geochem. Polar Res. Adv. Space Res. Vadose Zone J. GEOL BELG J. Afr. Earth. Sci. ESTUD GEOL-MADRID TELLUS B J. Clim. Russ. Meteorol. Hydrol. Solid Earth STRATIGRAPHY Polar Sci. GFF Weather Forecasting J. Mar. Syst. OCEANOGRAPHY Terra Nova BSGF-EARTH SCI B ACTA GEOL SIN-ENGL CHINESE GEOGR SCI J. Geol. Soc. India ACTA CARSOLOGICA Journal of Futures Markets Org. Geochem. Newsl. Stratigr. Surv. Rev. Econom. Rev. Economics of Energy & Environmental Policy Andean Geol. Hydrol. Earth Syst. Sci. EPISODES Journal of Commodity Markets J PALAEOGEOG-ENGLISH Review of Industrial Organization Q. J. Eng. Geol. Hydrogeol. ARCHAEOMETRY Acta Oceanolog. Sin. Atmos. Res. Atmos. Meas. Tech. GEOCHRONOMETRIA Miner. Deposita Economic Geography J. Seismic Explor. Geochim. Cosmochim. Acta South African Journal of Economic and Management Sciences Big Earth Data Social Choice and Welfare Acta Geochimica J Hum Resour Geostand. Geoanal. Res. Acta Montan. Slovaca Aquat. Geochem. Nat. Hazards Earth Syst. Sci. Contrib. Mineral. Petrol. Geol. Ore Deposits WIRES WATER Geosci. Can. J. Hydrol. Helgol. Mar. Res. ACTA GEOL POL Atmos. Chem. Phys. Asia-Pac. J. Atmos. Sci. Geosci. Front. Geobiology Int. J. Climatol. Mineral. Mag. J. Adv. Model. Earth Syst. IZV-PHYS SOLID EART+ Stud. Geophys. Geod. J. Atmos. Chem. Appl. Clay Sci. Q J Econ Basin Res. Mon. Weather Rev. Annu. Rev. Earth Planet. Sci. Geochem. Trans. J IBER GEOL Russ. Geol. Geophys. Am. J. Sci. Geophys. Prospect. Geomag. Aeron. GEOLOGY J. Atmos. Sol. Terr. Phys. GROUNDWATER Ocean Modell. Geosci. Data J.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1